Skip to main content
. 2021 Aug 15;69:102724. doi: 10.1016/j.amsu.2021.102724

Fig. 1.

Fig. 1

Postoperative overall survival of patients with benign disease/no pathology (dashed lines) and adenocarcinoma (solid lines). Inserted figure is the observed (solid lines) and predicted survival (dashed lines) of patients with adenocarcinoma. The curves are not significantly different (<75 years, p = 0.8438; ≥ p = 0.8955).